Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT06801236

Public ClinicalTrials.gov record NCT06801236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ACE-232 in Patients With Metastatic Castration-Resistant Prostate Cancer (CRPC)

Study identification

NCT ID: NCT06801236
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Acerand Therapeutics (Hong Kong) Limited; Industry
Enrollment: 67 participants

Conditions and interventions

Conditions

Interventions

ACE-232 tablets Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Male
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 11, 2025
Primary completion: Feb 29, 2028
Completion: Jul 31, 2028
Last update posted: Apr 8, 2026

2025 – 2028

United States locations

U.S. sites: 8
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of California San Diego, Moores Cancer Center	La Jolla	California	92093	Recruiting
Moffitt Cancer Center, Tampa	Tampa	Florida	33612	Recruiting
University of Maryland, Greenebaum Comprehensive Cancer Center	Baltimore	Maryland	21201	Recruiting
Harvard Medical School-Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
M Health Fairview Clinics and Surgery Center	Minneapolis	Minnesota	55455	Recruiting
Xcancer (Urology Cancer Center)	Omaha	Nebraska	68130	Recruiting
Carolina Urologic Research Center	Myrtle Beach	South Carolina	29572	Recruiting
Fred Hutchinson Cancer Research Center	Seattle	Washington	98109	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06801236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 8, 2026 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06801236 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →